Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 22:2018:9647247.
doi: 10.1155/2018/9647247. eCollection 2018.

Current Management of Pancreatic Neuroendocrine Tumors: From Demolitive Surgery to Observation

Affiliations
Review

Current Management of Pancreatic Neuroendocrine Tumors: From Demolitive Surgery to Observation

Ilenia Bartolini et al. Gastroenterol Res Pract. .

Abstract

Incidental diagnosis of pancreatic neuroendocrine tumors (PanNETs) greatly increased in the last years. In particular, more frequent diagnosis of small PanNETs leads to many challenging clinical decisions. These tumors are mostly indolent, although a percentage (up to 39%) may reveal an aggressive behaviour despite the small size. Therefore, there is still no unanimity about the best management of tumor smaller than 2 cm. The risks of under/overtreatment should be carefully evaluated with the patient and balanced with the potential morbidities related to surgery. The importance of the Ki-67 index as a prognostic factor is still debated as well. Whenever technically feasible, parenchyma-sparing surgeries lead to the best chance of organ preservation. Lymphadenectomy seems to be another important prognostic issue and, according to recent findings, should be performed in noninsulinoma patients. In the case of enucleation of the lesion, a lymph nodal sampling should always be considered. The relatively recent introduction of minimally invasive techniques (robotic) is a valuable option to deal with these tumors. The current management of PanNETs is analysed throughout the many available published guidelines and evidences with the aim of helping clinicians in the difficult decision-making process.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary and proposal of a management flow chart in PanNETs.
Figure 2
Figure 2
Summary of all surgical options available to deal with PanNETs. A tailored, single-patient, focused approach remains the best option.

References

    1. Kuo E. J., Salem R. R. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size. Annals of Surgical Oncology. 2013;20(9):2815–2821. doi: 10.1245/s10434-013-3005-7. - DOI - PubMed
    1. Sadot E., Reidy-Lagunes D. L., Tang L. H., et al. Observation versus resection for small asymptomatic pancreatic neuroendocrine tumors: a matched case-control study. Annals of Surgical Oncology. 2016;23(4):1361–1370. doi: 10.1245/s10434-015-4986-1. - DOI - PMC - PubMed
    1. Sandvik O. M., Søreide K., Gudlaugsson E., Kvaløy J. T., Søreide J. A. Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria. British Journal of Surgery. 2016;103(3):226–232. doi: 10.1002/bjs.10034. - DOI - PMC - PubMed
    1. Cheema A., Weber J., Strosberg J. R. Incidental detection of pancreatic neuroendocrine tumors: an analysis of incidence and outcomes. Annals of Surgical Oncology. 2012;19(9):2932–2936. doi: 10.1245/s10434-012-2285-7. - DOI - PubMed
    1. Bettini R., Partelli S., Boninsegna L., et al. Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. Surgery. 2011;150(1):75–82. doi: 10.1016/j.surg.2011.02.022. - DOI - PubMed

LinkOut - more resources